Healthmonix Advisor

Yesterday afternoon, CMS released the 2018 Final Rule for the MACRA Quality Payment Program. The rule finalized some changes we were expecting, and others that came as a surprise. The second year of the Quality Payment Program will be more advanced than the first, aiming to get clinicians ready for the even more intense requirements mandated by the MACRA legislation to be enacted in 2019.

The Second National MACRA MIPS/APM Summit is the leading forum on MACRA, MIPS, APMs, and other Value Based Payment Models. With no fee increases across-the-board for physicians from 2020-2025, value-based payment is going to become key for any health system's viability. Healthmonix was pleased to attend this summit and see MACRA policy and perspective in the making, with thought leaders in the medical, research, and business fields convening to break down MACRA and it's implementation now, as well as look towards the future of what MACRA can and should be.

We put together a brief list of takeaways from this event.

CMS has recently lifted requirements for physicians participating in various bundled-payment initiatives. In a Proposed Rule released in August, the Health and Human Services agency proposed canceling the mandatory Episode Payment Models and Cardiac Rehabilitation Incentive payment model, which were scheduled to begin in January. HHS also plans to reduce the number of geographic areas mandatorily participating in the Comprehensive Care for Joint Replacement (CJR) model from 67 down to 34.

Value-based payment models aim to address rising healthcare costs, clinical inefficiency and duplication of services. To survive in an industry with increasing competition a solid understanding of the business case for implementing value based care is imperative.

The most notable value based care program currently is the MACRA Quality Payment Program, which provides the option to participate in MIPS or an advanced APM. If you’ve been keeping up with our blog posts recently you may already know that the deadline for the last MIPS performance period of the year is October 2nd, and that as long as you start collecting data by that date you will be able to report successfully.

To prosper in an industry challenged by constantly changing reform and increasing competition, healthcare organizations must continually increase their quality of care and become more efficient. Reporting MIPS in 2017 is a low-risk, high reward condition to stress-test your clinical workflows for optimized value-based program reporting.

CMS is worried about how few providers understand or are even aware of MACRA. As we near October 2nd, the deadline by which 400,000 eligible providers must start tracking data in order to avoid a financial penalty in 2019, CMS has found that around 40% of clinicians and even fewer nurse practitioners have a solid understanding of the requirements. Their concern is only supported by a recent Integra Connect survey which finds that most specialty physicians have not yet made the operational changes necessary to succeed in the new world of value based care.

Statistically, you aren’t sure how you’re supposed to comply with quality reporting requirements this year. As late as June 2017, the majority of providers were still unfamiliar or only somewhat familiar with MACRA; only 9 percent described themselves as “very familiar”. But unless you’re a part of that 9 percent, we highly recommend that you take some time ASAP to familiarize yourself with the requirements and to make a plan for the rest of the year. And as part of that plan, here are four reasons why we recommend that you select Improvement Activities for your practice today (yes, literally today):

Over the last two weeks, we've shown you how to select quality measures. Now that you've decided which measures to collect data for, it's time to start reporting! If you have reported PQRS in the past, the process will be similar with a few major changes. Eligible clinicians who are new to reporting may want to first check out our article on the basics of quality measures prior to understanding how to completely report a quality measure.

In our last post, we covered some of the basic questions you should be asking yourself when choosing quality measures to report under MIPS. In part two of this series, we go over a few more specific questions that can help guide you to picking the best measures for your practice.

So you’re a MIPS-eligible clinician (if you’re not sure about your participation status, check out our post about how to find out), and you don’t want your practice to miss out on the reimbursement you know you deserve. But how should you decide which quality measures to actually report to CMS? How can you know if the measures you’re choosing will ultimately lead to reporting success, and is there a way to use those measures to not just fulfill the requirements but actually improve your practice? We’ve put together a two-part post to guide you through the most important factors to consider when deciding what might be best for you and your practice. First, the basics: